HEALTHTECH SCIENCES AS
Score · fiscal year 2025
65of 100
How to read this: the company is ahead of 80 % of small companies in the same sector in 2025. What does this mean?
Rank: 6,045 of 30,442 · Handel
Profile
Lion · Leader
High profitability, high solidity
Position against comparable companies in 2025, not a verdict on the company. Based on profitability 90 and solidity 70 out of 100 among small companies in the same sector in 2025. Methodology
Against the sector
HEALTHTECH SCIENCES AS is 15 points above the median for small companies in the same sector in 2025.
Median score 50 among 28,491 companies.
Against small companies in the same sector in 2025: operating margin 19.4% (median 2.2%) and equity ratio 67.4% (median 35.1%).
The numbers behind the score
| Measure | Company | Median |
|---|---|---|
| Operating revenue | 5 MNOK | 3 MNOK |
| Operating margin | 19.4% | 2.2% |
| Profit margin | 19.5% | 2.0% |
| Return on assets | 42.4% | 3.2% |
| Equity ratio | 67.4% | 35.1% |
| Debt-to-equity | 0.48 | 1.05 |
| Current ratio | 3.39 | 1.64 |
| Revenue growth | −23.4% | 3.8% |
| Revenue per employee | 0.85 MNOK | 1.60 MNOK |
The median and “ahead of” refer to small companies in the same sector in 2025. The bar shows the share of companies the figure is ahead of.
With an index of 65, HEALTHTECH SCIENCES AS does better than 80% of small companies in the same sector (28,889 companies) in 2025.
Score 2023–2025
- HEALTHTECH SCIENCES AS
- Median: small companies in the same sector
HEALTHTECH SCIENCES AS has a score of 65 for 2025, rank 6,045 of 30,442 in the sector.
Strongest: Profitability: percentile 90 against peers, operating margin 19.4% against a median of 2.2%. Liquidity: percentile 75 against peers, current ratio 3.39 against a median of 1.64.
Weakest: Growth: percentile 17 against peers, revenue growth −23.4% against a median of 3.8%.
Worth a closer look
- What lies behind weak growth, and will it last?
Written by fixed rules from the figures. Describes the figures, does not explain causes. Not investment or financial advice. How the summary is made
What the numbers say
HEALTHTECH SCIENCES AS had an operating margin of 19.4% and an equity ratio of 67.4% in 2025, and ranks 6,045 of 30,442 in Handel.
From 2024 to 2025: the equity ratio rose from 39.5% to 67.4% and the operating margin rose from 12.6% to 19.4%.
This text is generated automatically from the 2025 accounts.
Three simple methods
The methods give between 2 MNOK and 10 MNOK.
| Method | Multiple | Estimate |
|---|---|---|
| P/E | 10.0 | 10 MNOK |
| EV/EBIT | 8.0 | 8 MNOK |
| P/B | 1.0 | 2 MNOK |
A mechanical estimate from public accounts, not advice. Mechanical estimate from public accounts with fixed multiples. Not a valuation and not advice to buy or sell. The multiples are provisional default values and must be adjusted per sector before the figures are used for anything. See the calculation
Worth a closer look
No rules were triggered for this year.
Indications based on the latest annual accounts from open data. Not investment or financial advice.
Data quality
No anomalies found in the figures.
Scenario analysis: the sector's weakest year
We have no accounts for 2017, the sector's weakest year, for this company.
The sector's weakest year was 2017, with a median operating margin of −134.9%. Based on the 10 fiscal years we have. The analysis grows as more years are fetched or imported. Methodology
What the score is made of
| Profitability | 90 | weight 30% |
|---|---|---|
| Solidity | 70 | weight 25% |
| Liquidity | 75 | weight 15% |
| Growth | 17 | weight 15% |
| Consistency | 47 | weight 15% |
Durability: 50 (average over 3 years)
Index version 2. Data completeness 100%: the share of the weights that had data.
Questions and answers
How profitable is HEALTHTECH SCIENCES AS?
The operating margin was 19.4% in 2025, against a median of 2.2% among small companies in the same sector. Return on assets was 42.4%.
How solid is HEALTHTECH SCIENCES AS?
The equity ratio was 67.4% in 2025 (median 35.1%). Debt-to-equity was 0.48 (median 1.05).
What is the liquidity of HEALTHTECH SCIENCES AS like?
The current ratio was 3.39 in 2025 (median 1.64).
How does HEALTHTECH SCIENCES AS compare in Handel?
HEALTHTECH SCIENCES AS ranks 6,045 of 30,442 in Handel for 2025. Among companies of the same size (small companies) it ranks 5,699 of 28,889. Revenue changed by −23.4% from the year before.
From the Central Coordinating Register
- Org. no.
- 892976562
- Legal form
- AS
- Sector
- Handel (46.460)
- Size tier
- small
- Employees
- 6 registered 10 January 2026
- Founded
- 12 August 2008 18 years in operation
- Share capital
- 0.22 MNOK
- Business address
- Rieber-Mohns veg 2, 5230 PARADIS (BERGEN)
- Municipality
- Bergen rank 9 of 11 in KOSTRA group 12
- Latest accounts filed
- 2025
Source: Central Coordinating Register, Brønnøysund Register Centre. The employee count is reported by the company and may be older than the accounts. See the company at the Brønnøysund Register Centre
Ownership and roles
- Chief executive
- Roger Hovland
- Chair of the board
- Kari Tvete Solvang
- Board member
- Brit Solvang Karlson
- Board member
- Roger Hovland
- Board member
- Thomas Aksnes
- Auditor
- STATSAUTORISERT REVISOR TOM OVE OLSEN AS
Source: Central Coordinating Register, fetched 25 October 2026. Only names are shown.
Owners and shareholdings will appear here once the shareholder data extract is in place.
Coming · not built yet
Error in the data?
Do you see an error in the figures or in how the company is mapped (sector, holding, group)? Let us know. Corrections require documentation.
Figures last fetched 26 October 2026.
Year by year · 2023–2025
| Key figure | 2023 | 2024 | 2025 | Trend |
|---|---|---|---|---|
| Index | 15 | 68 | 65 | |
| Rank | 23,613 | 4,579 | 6,045 | |
| Operating margin | −9.7% | 12.6% | 19.4% | |
| Return on assets | −29.9% | 52.3% | 42.4% | |
| Equity ratio | −9.0% | 39.5% | 67.4% | |
| Current ratio | 1.71 | 3.23 | 3.39 | |
| Revenue growth | – | 19.8% | −23.4% |
Accounts
From the Brønnøysund Register Centre, in the company's reporting currency (NOK).
| Key figure | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating revenue | 5.5 MNOK | 6.6 MNOK | 5.1 MNOK |
| Operating profit | −0.5 MNOK | 0.8 MNOK | 1.0 MNOK |
| Profit before tax | −0.7 MNOK | 0.9 MNOK | 1.0 MNOK |
| Net profit | −0.7 MNOK | 0.9 MNOK | 1.0 MNOK |
| Financial expenses | 0.2 MNOK | 0.1 MNOK | 0.1 MNOK |
| Total assets | 1.6 MNOK | 1.9 MNOK | 2.6 MNOK |
| Current assets | 1.4 MNOK | 1.7 MNOK | 2.2 MNOK |
| Equity | −0.1 MNOK | 0.7 MNOK | 1.7 MNOK |
| Retained earnings | −5.5 MNOK | −4.6 MNOK | −3.6 MNOK |
| Total liabilities | 1.7 MNOK | 1.1 MNOK | 0.8 MNOK |
| Current liabilities | 0.8 MNOK | 0.5 MNOK | 0.7 MNOK |
Source: Brønnøysund Register Centre (Register of Company Accounts), fetched 26 October 2026, accounts id 7034196.
Further
Similar companies
- NORD-LOCK AS index 65, rank 6,042 · compare
- VIKEN BIL SENTERET AS index 65, rank 6,044 · compare
- SAND KOLONIAL AS index 65, rank 6,046 · compare
- AL-MOSTAFA ASIAN FOOD AS index 65, rank 6,047 · compare
- AQUAFIND AS index 65, rank 6,048 · compare